Scarica l'app Stockscreener
182.51
0.91%
-1.67
Dopo l'orario di chiusura:
182.51
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$184.18
Aprire:
$183.2
Volume 24 ore:
738.19K
Relative Volume:
0.73
Capitalizzazione di mercato:
$20.30B
Reddito:
$10.52B
Utile/perdita netta:
$999.00M
Rapporto P/E:
21.82
EPS:
8.3628
Flusso di cassa netto:
$1.22B
1 W Prestazione:
-3.53%
1M Prestazione:
+2.38%
6M Prestazione:
+5.10%
1 anno Prestazione:
+15.13%
Intervallo 1D:
$182.08
$184.19
Intervallo di 1 settimana:
$182.08
$189.38
Portata 52W:
$148.70
$197.55
Quest Diagnostics Inc Stock (DGX) Company Profile
Nome
Quest Diagnostics Inc
Settore
Industria
Telefono
(973) 520-2700
Indirizzo
500 PLAZA DRIVE, SECAUCUS
Confronta DGX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
182.51 | 20.49B | 10.52B | 999.00M | 1.22B | 8.3628 |
|
TMO
Thermo Fisher Scientific Inc
|
572.77 | 216.12B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.25 | 160.43B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
714.10 | 57.29B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
145.49 | 41.98B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
225.85 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-04-02 | Iniziato | Redburn Atlantic | Buy |
| 2025-03-04 | Downgrade | Citigroup | Buy → Neutral |
| 2025-01-06 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-12-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | Ripresa | Jefferies | Buy |
| 2024-10-23 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-08-28 | Ripresa | Evercore ISI | In-line |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-02-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2023-12-12 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-06-29 | Iniziato | Piper Sandler | Neutral |
| 2023-05-02 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-04-03 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-01-23 | Iniziato | Evercore ISI | In-line |
| 2022-11-17 | Downgrade | Citigroup | Neutral → Sell |
| 2022-08-22 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-04-04 | Downgrade | Citigroup | Buy → Neutral |
| 2022-02-23 | Downgrade | UBS | Buy → Neutral |
| 2022-02-02 | Downgrade | Jefferies | Buy → Hold |
| 2022-01-28 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-05-04 | Aggiornamento | UBS | Neutral → Buy |
| 2021-03-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-10-21 | Aggiornamento | Argus | Hold → Buy |
| 2020-07-29 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-14 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-06-09 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2020-06-02 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-04-28 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-27 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-04-27 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-03-27 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-08 | Iniziato | Wells Fargo | Underweight |
| 2020-01-07 | Downgrade | Barclays | Overweight → Equal Weight |
| 2019-12-19 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-07-15 | Downgrade | Goldman | Neutral → Sell |
| 2019-04-02 | Aggiornamento | Jefferies | Hold → Buy |
| 2019-03-18 | Ripresa | Credit Suisse | Neutral |
| 2019-01-31 | Downgrade | Argus | Buy → Hold |
| 2019-01-17 | Iniziato | UBS | Neutral |
| 2019-01-03 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2018-11-30 | Downgrade | Goldman | Buy → Neutral |
Mostra tutto
Quest Diagnostics Inc Borsa (DGX) Ultime notizie
New York State Common Retirement Fund Sells 7,619 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Can Quest Diagnostics Incorporated (QDI) stock hold up in economic slowdownTrade Exit Report & Safe Entry Zone Identification - Newser
Looking Into Quest Diagnostics Inc's Recent Short Interest - Benzinga
Will Quest Diagnostics Incorporated stock outperform benchmarksJuly 2025 Trends & Real-Time Chart Breakout Alerts - Newser
1,325,624 Shares in Quest Diagnostics Incorporated $DGX Purchased by Norges Bank - MarketBeat
Korea Investment CORP Purchases 12,300 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Published on: 2025-12-03 05:06:27 - Newser
Blueshift Asset Management LLC Has $636,000 Stock Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Is Quest Diagnostics Incorporated (QDI) stock ideal for retirement investorsPortfolio Performance Report & Daily Volume Surge Signals - Newser
Is Quest Diagnostics Incorporated stock nearing a technical breakoutExit Point & Expert Approved Momentum Ideas - Newser
Mackenzie Financial Corp Has $28.11 Million Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Schroder Investment Management Group Buys 122,646 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Is Quest Diagnostics Incorporated stock cheap vs fundamentalsJuly 2025 Snapshot & AI Forecasted Stock Moves - Newser
Why analysts maintain buy rating on Quest Diagnostics Incorporated stockBreakout Watch & Low Drawdown Momentum Ideas - Newser
Russell Investments Group Ltd. Acquires 25,768 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Published on: 2025-12-02 04:36:26 - Newser
How cyclical is Quest Diagnostics Incorporated stock compared to rivals2025 Analyst Calls & Real-Time Chart Breakout Alerts - Newser
Distillate Capital Partners LLC Sells 4,577 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Hsbc Holdings PLC Reduces Stock Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock - sharewise.com
Quest Diagnostics, Octave Collaborate to Expand Multiple Sclerosis Disease Activity Test Access - marketscreener.com
Octave Bio lands massive deal with Quest Diagnostics that will expand reach of its multiple sclerosis tests - The Business Journals
Quest Diagnostics (NYSE: DGX) to offer Octave MSDA MS blood test at 7,000 U.S. sites - Stock Titan
First National Advisers LLC Purchases Shares of 8,980 Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Insider Sold Shares Worth $10,589,760, According to a Recent SEC Filing - marketscreener.com
Skandinaviska Enskilda Banken AB publ Raises Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
J. Davis Sells 55,093 Shares of Quest Diagnostics (NYSE:DGX) Stock - MarketBeat
Quest Diagnostics Incorporated $DGX Shares Sold by Grantham Mayo Van Otterloo & Co. LLC - MarketBeat
Northwest & Ethical Investments L.P. Invests $1.10 Million in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Incorporated $DGX Stock Holdings Lifted by Franklin Resources Inc. - MarketBeat
Prudential Financial Inc. Grows Stock Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Does Quest Diagnostics Offer Value After 8% Surge and New Partnerships in 2025? - Yahoo Finance
Insider Sell: Vicky Gregg Sells Shares of Quest Diagnostics Inc (DGX) - GuruFocus
Chmn Davis Sells 55,093 ($10.6M) Of Quest Diagnostics Inc [DGX] - TradingView
Dir Gregg Sells 1,250 ($239.7K) Of Quest Diagnostics Inc [DGX] - TradingView
Quest Diagnostics (DGX) CEO James E. Davis exercises options and sells common stock - Stock Titan
[Form 4] QUEST DIAGNOSTICS INC Insider Trading Activity - Stock Titan
Advisors Asset Management Inc. Reduces Stock Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Incorporated $DGX Shares Acquired by Charles Schwab Investment Management Inc. - MarketBeat
Can Quest Diagnostics Incorporated stock deliver sustainable ROEQuarterly Profit Report & AI Driven Stock Price Forecasts - BỘ NỘI VỤ
HOLX vs. DGX: Which Healthcare Diagnostics Stock Is the Better Bet? - Finviz
Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-Term - sharewise.com
Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Rhumbline Advisers Reduces Stock Position in Quest Diagnostics Incorporated $DGX - MarketBeat
[144] QUEST DIAGNOSTICS INC SEC Filing - Stock Titan
Dir Gregg Files To Sell 1,250 Of Quest Diagnostics Inc [DGX] - TradingView
Quest Diagnostics Incorporated $DGX Stock Holdings Lifted by DNB Asset Management AS - MarketBeat
Should You Hold Quest Diagnostics Stock in Your Portfolio for Now? - sharewise.com
DGX Stock Up on New Blood Test Development Deal With MD Anderson - MSN
Quest Diagnostics Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Is Quest Diagnostics Incorporated (QDI) stock protected from inflationQuarterly Performance Summary & Expert Curated Trade Ideas - newser.com
Quest Diagnostics Inc Azioni (DGX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.18%
0.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):